Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2023
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
H Borghaei, F de Marinis, D Dumoulin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
F Peyraud, J-P Guégan, D Bodet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2026
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
A Mavrikios, M Bortolot, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
ESMO Open
|
January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
M-L Meyer, S Peters, P A Jänne, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2023
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
H Borghaei, F de Marinis, D Dumoulin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
F Peyraud, J-P Guégan, D Bodet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2026
Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?
A Mavrikios, M Bortolot, C Le Péchoux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
A Passaro, N Leighl, F Blackhall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
ESMO Open
|
January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
M-L Meyer, S Peters, P A Jänne, et al.
Page
of 6